Latest news
Loading news…
BrightPath Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Tokyo, Japan Founded 2003 11-50 employees For Profit
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Ticker
4594
TYO - Tokyo Stock Exchange
Patents
18
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- 4594
- Exchange
- TYO - Tokyo Stock Exchange
- IPO date
- Oct 22, 2015
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 9
- Patents granted
- 18
- Trademarks
- 4
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2003
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 12
- HQ
- Tokyo, Japan
- Region
- Asia-Pacific (APAC)
- Exit date
- Oct 22, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -1
- Trend (30d)
- 4
- Trend (90d)
- 5.1
Acquisitions by BrightPath Biotherapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at BrightPath Biotherapeutics
Founder
President and CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BrightPath Biotherapeutics
Loading news…
FAQs about BrightPath Biotherapeutics
People who checked this page also checked these
Sectors BrightPath Biotherapeutics invests & acquires in
Browse the full Acquirezy directory.